A less-invasive treatment technique called hemi-gland cryoablation (HGCryo)—destroying the areas of the prostate where cancers are located by freezing them—provides a high rate of effective prostate cancer control, according to a new study published in The Journal of Urology, Official Journal of the American Urological Association (AUA). “Freedom from cancer, as documented by biopsy, was
New blood test for prostate cancer could help monitor patients without invasive procedure and would reveal if they need urgent treatment Prostate cancer is most common among UK men with 50,000 diagnosed a year Study published in Journal of Clinical Investigation offers hope of a blood test At present the cancer is diagnosed through physical
Prostate cancer is the most common noncutaneous malignancy in the United States and is responsible for many male deaths. The development of prostate carcinogenesis is initially androgen-dependent. However, the progression of castration-resistant prostate cancer (CRPC) following androgen deprivation therapy is a major clinical problem. Although enzalutamide and abiraterone have been approved for CRPC hormone therapy,
A new study looks to move doctors and patients closer to earlier and more precise detection of recurrent prostate cancer that would clarify treatment decisions and lead to more confident courses of action and better health outcomes. A multi-center trial registry testing the use of a new imaging tracer—prostate specific membrane antigen (PSMA) – is
Many men with prostate cancer rely on common testosterone-blocking drugs as a part of their treatment. But those so-called antiandrogens also might put them at risk for a deadly heart condition, according to new research. In a study published Monday in the American Heart Association journal Circulation, researchers looked at how several testosterone-blocking drugs affect
Hormone therapy for prostate cancer increases risk of DEMENTIA by 20%, study finds The large study in the US looked at nearly 155,000 men with an average age of 74 It found those given the therapy had a 20% increased risk of any type of dementia A hormone therapy used to treat prostate cancer in men
An innovative new digital model of follow-up care for prostate cancer allows patients to see test results online as soon as they become available, after a report was published in BMC Cancer. Researchers from the University of Southampton, funded by the Movember Foundation and delivered in partnership with Prostate Cancer UK, trialled the True NTH
Researchers in New York have found that treating human prostate cancer cells with a drug that targets a protein called PHLPP2 may prevent the cancer cells from spreading to other organs in the body. The study, which will be published May 15 in the Journal of Cell Biology, reveals that inhibiting PHLPP2 lowered the levels
A study published recently in the Journal of Clinical Oncology Precision Oncology, an American Society of Clinical Oncology (ASCO) journal, outlines findings from the largest-ever prospective genomic analysis of advanced prostate cancer tumors. Using comprehensive genomic profiling (CGP) to analyze thousands of tumor samples from men with advanced prostate cancers, the researchers identified that 57
Scientists have identified a gene mutation in the tumours of men with prostate cancer that is linked to very poor survival—and which could be used to pick out patients for more intensive treatment. Men with mutations in the retinoblastoma gene in their tumours were more than three times as likely to die and nearly seven
Prostate cancer and death rates have plummeted worldwide, study reveals About one in nine men develop prostate cancer over the course of their lives In 1994, a blood test for the cancer was approved by the FDA But the test led to over-diagnosis and has fallen out of favor In 44 countries, prostate cancer rates
TUESDAY, Feb. 19, 2019 — Metastasis-free survival is significantly longer among men with nonmetastatic, castration-resistant prostate cancer treated with darolutamide versus placebo, according to a phase 3 study published online Feb. 14 in the New England Journal of Medicine to coincide with the American Society of Clinical Oncology annual Genitourinary Cancers Symposium, held from Feb.
What are the symptoms that indicate a change in the prostate? Prostate cancer is the most common cancer in men. Every year, around 60,000 new cases occur. According to information of the German cancer society every fourth Tumor in men develops in the prostate. Approximately 10 percent of the cases end fatally. Thus, the prostate
Experts from the Universities of Bath and Seville have carried out a series of experiments by which, for the first time, they have characterized the normal electrical activity in PC-3 prostate cancer cells in real time, with a resulting low-frequency electrical pattern between 0.1 and 10 Hertz. “We have observed that this electrical activity evolves
PSA screening cuts deaths from prostate cancer by some 30 percent. This research was based on data of 20,000 men monitored for more than two decades. The men’s initially measured PSA levels proved highly significant as a predictor of future cancer risk. “This research is important, because it shows the long-term effects of an organized
YouTube fueling prostate myths: 77% of 150 most watched videos ‘have factual errors’ There are well over half a million videos about prostate cancer on YouTube More than 77 percent of the videos included incorrect or biased information about the disease About half of the videos did not describe the recommended ‘shared decision-making’ doctors and
Prostate cancer is the second most common cancer in American men. But black men bear a disproportionate burden of its effects. It’s more common—and more than twice as deadly—among black men compared to their white counterparts. Yet the United States Preventive Services Task Force (USPSTF) recommendations for prostate cancer screening do not differentiate for race,
High-risk prostate cancer, that which has continued to grow but not yet metastasized, is commonly treated with combination therapies. Each method has pros and cons, but there is little clarity whether one might be more effective than the other. For the first time, researchers have shown that more patients live longer if treated with the
(HealthDay)—Patients with prostate cancer receiving care in a Medicare-only setting are more likely to receive guideline-discordant imaging, according to a study published online Aug. 17 in JAMA Network Open. Danil V. Makarov, M.D., from New York University School of Medicine in New York City, and colleagues examined the correlation between prostate cancer imaging rates and
Routine testing for prostate cancer is not recommended for most men because the benefit is small and uncertain and there are clear harms, say a panel of international experts in The BMJ today. But they acknowledge that some men, such as those with a family history of prostate cancer, may be more likely to consider
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok